Analysis-Alzheimer's drug breakthrough big boost for Roche, Eli Lilly
Go back to Analysis-Alzheimer's drug breakthrough big boost for Roche, Eli Lilly| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 223.15 -2.21 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.36 | 52 Week High | $333.65 | |||
| Open | $226.94 | 52 Week Low | $223.02 | |||
| Day High | $229.19 | P/E | 28.57 | |||
| Day Low | $222.36 | EPS | $7.81 | |||
| Volume | 393,010 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1150.57 -19.57 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1170.14 | 52 Week High | $88.16 | |||
| Open | $1174.71 | 52 Week Low | $67.88 | |||
| Day High | $1188.88 | P/E | 266.34 | |||
| Day Low | $1146.55 | EPS | $4.32 | |||
| Volume | 996,904 | |||||
